CXCL12 and pulmonary fibrosis: Current proof of concept study is limited by the fact that we have only tested one-time point of day seven after gene transfer; long term studies should be evaluated to see the beneficial effect of SDF-1 gene transfer in bleomycin-induced lung fibrosis.